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Abstract
A study of florfenicol (FF) and its metabo-
lite florfenicol amine (FFA) in pig cerebrospi-
nal fluid was conducted following repeated 
intramuscular administration of the original 
(reference) and a generic veterinary medicinal 
product (VMP) under the same experimental 
conditions (20 mg FF/kg body weight, 48-hour 
interval). Both VMPs are solutions for injection 
containing FF as an active substance in the con-
centration of 300 mg/mL and have been author-
ized in Croatia for use in cattle and pigs. In this 
study, clinically healthy pigs were randomly 
divided into three groups. The first group was 
treated with the reference VMP, the second 
with the generic VMP, while the third served 
as the control group. Animals were sacrificed 
at 216, 288 and 384 hours after the first drug 
administration. Cerebrospinal fluid samples 
were analysed by the optimized and validated 
high-performance liquid chromatography-di-
ode array detector method (HPLC-DAD). The 
solid-phase extraction (SPE) technique was 
chosen for sample preparation. The HPLC-
DAD method provides good linearity over the 
concentration range of 0.05 to 5.00 µg/mL for 
FF and FFA. Limits of detection were 0.0023 
µg/mL for FF and 0.0100 µg/mL for FFA. Ex-
traction recoveries of FF were from 86.6% to 
111.8%, and of FFA from 91.7% to 98.8%. The 
SPE-HPLC-DAD method has been demonstrat-
ed to be a selective, sensitive and suitable ana-
lytical method for the determination of FF and 
FFA in cerebrospinal fluid. The present study 
was based on a preliminary study that quan-
tified FF in pig plasma at 216 hours after the 
first application of reference or generic VMP. 
However, FF and FFA were not detected in any 
of the cerebrospinal fluid samples during the 
experimental period. According to the nature 
of biological fluids, the SPE-HPLC-DAD meth-
od can be suitable for further pharmacokinetic 
studies of FF in pig plasma and serum after in-
tramuscular administration of VMPs.
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Introduction
Florfenicol (FF) is a synthetic 
broad-spectrum antibiotic developed 
for veterinary use. It belongs to the am-
phenicol group of antibiotics (Figure 1), 
like its structural analogues thiamphen-
icol and chloramphenicol (CAP). Orig-
inal (reference) and generic veterinary 
medicinal products (VMPs) containing 
FF as an active substance are available 
for parenteral or oral administration in 
cattle, pigs, fish, chickens and sheep. FF 
is used for metaphylaxis and treatment 
of respiratory infections etiologically as-
sociated with Actinobacillus pleuropneu-
moniae, Pasteurella multocida, Bordetella 
bronchiseptica and Mannheimia haemolyti-
ca (Dowling, 2000). The mechanism of FF 
action includes protein synthesis inhibi-
tion at the ribosomal level of susceptible 
bacteria.
FF is distributed mainly into the 
lungs, muscle, bile, kidney and urine. 
Radiometric studies of 14C-FF conducted 
in pigs following various routes of 
administration (EMA, 1999) showed that 
FF has a major fraction of radioactivity 
(45 to 60%) in urine, followed by 
florfenicol amine (FFA, 11.2 to 17%), its 
marker residue. In pharmacokinetic (PK) 
and pharmacodynamic (PD) studies of 
FF in pigs, peak plasma concentrations 
in the range from 3 to 12 µg/mL were 
reported within 5 hours of intramuscular 
administration (Voorspoels et al., 1999; 
Liu et al., 2003; Geng et al., 2015; Qian 
et al., 2017; de Smet et al., 2018; Lei 
et al., 2018). The dispositions of FF in 
cerebrospinal fluid (CSF) were studied 
mainly in calves. After intravenous 
administration of FF to calves at a dose 
of 20 mg/kg body weight (bw), FF 
penetrated into CSF, reaching a peak 
concentration of 4.7 µg/mL (de Craene et 
al., 1997). The outcomes of FF exposure 
in pig CSF after repeated intramuscular 
administration of 20 mg FF/kg bw have 
not been fully documented. 
Plasma, serum and CSF are very 
similar biological fluids. CSF is nearly 
protein-free compared with plasma, 
for CSF formation begins as plasma is 
filtered across the permeable choroidal 
capillaries (Johanson et al., 2008). Due 
to the similar composition, CSF is a 
matrix in which experimental data 
can provide preliminary information 
about PK/PD changes in plasma or 
serum. Furthermore, the penetration of 
antibiotics into CSF following various 
routes of drug administration and 
their concentration levels are relevant 
data for neurological toxicity studies. 
Neurological toxicity associated with 
antibiotic use (Grill and Maganti, 2011) 
or combined administration of antibiotic 
and antiepileptic/anti-inflammatory 
drugs (Esposito et al., 2017) have shown 
that the toxic effects are directly related 
to brain tissue and CSF concentrations of 
administrated antibiotics.
A considerable number of analytical 
approaches for FF determination in 
biological fluids, edible tissues or 
feedstuffs have been reported. Those 
include gas chromatography (Shen et 
al., 2009; Liu et al. 2010), high(ultra)-
performance liquid chromatography 
(HPLC or UPLC) with ultraviolet detector 
(Yang et al., 2017; Patyra and Kwiatek, 
2019), mass spectrometer (Li et al., 2020) 
Figure 1. Chemical structures of amphenicols 
(CAP - chloramphenicol; FF - florfenicol; FFA - 
florfenicol amine; R1-3 - functional groups)
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or fluorescence detector (Xie et al., 2011; 
Wang et al., 2019), liquid chromatography-
tandem mass spectrometry (Imran et 
al., 2017; Xie et al., 2018; Kverme et al., 
2019), capillary electrochromatography 
(Valette et al., 2004) or immunochemical 
techniques (Fodey et al., 2013). However, 
no reports have described the method 
for FF or FFA quantification in pig CSF 
samples after repeated administration 
of the recommended dose of generic or 
reference VMPs.
The aim of this study was to develop 
a selective, sensitive and rapid HPLC 
method for FF and FFA determination 
in CSF. Due to possible antibiotic 
penetration into the CSF, we investigated 
the FF and FFA exposure in pig CSF after 
repeated intramuscular administration of 
reference or generic VMP.
Materials and methods
Animals and experimental design
The study was conducted using 
reference and generic VMPs from 
the Croatian market. Both VMPs are 
solutions for injection containing FF as 
an active substance in the concentration 
of 300 mg/mL and are indicated for use in 
cattle and pigs.
In this study, 18 clinically healthy pigs, 
commercial crossbred hybrids weighing 
80-90 kg were used. Animals were housed 
on a commercial farm (Žito d.o.o., Lužani, 
Croatia) under conditions compliant with 
good veterinary practices. Throughout 
the study, animals had ad libitum access 
to feed and water. Pigs were randomly 
divided into three groups of six, where 
one group was treated with the reference 
VMP, one with the generic VMP, and one 
served as the control group. Both VMPs 
were administrated in the recommended 
FF dose of 20 mg/kg bw by deep 
intramuscular injection using a 16-gauge 
needle into the neck muscles, twice at 48-
hour intervals. CSF samples were taken 
from the cranial cavity of slaughtered 
animals and collected in sterile tubes at 
216, 288 and 384 hours after the first drug 
administration. Samples were stored at 
-20 °C until analysis. 
The experiment was performed 
in abidance with the animal welfare 
principles, and was categorized as non-
aggressive. Animals were slaughtered at 
the end of the fattening period. The study 
was approved by the Ethics Committee 
of the Faculty of Veterinary Medicine, 
University of Zagreb. This study was 
supported by the Croatian Veterinary 
Institute (Zagreb, Croatia) under research 
project no. 048-0481186-1184 “The effects 
and transformation of veterinary drugs 
and vaccines in animals” granted by the 
Ministry of Science, Education and Sports 
of the Republic of Croatia.
Standards and sample preparation
FF (99.0% assay purity) was obtained 
from Sigma-Aldrich (Steinheim, 
Germany), CAP (99.8% assay purity) was 
provided by Dr Ehrenstorfer (Augsburg, 
Germany), while FFA (98.1% assay 
purity) came from Schering-Plough 
Essex Chemie AG (Luzern, Switzerland). 
HPLC-grade acetonitrile and water were 
purchased from Merck (Darmstadt, 
Germany). Analytical grade phosphoric 
acid (85 wt% in water) and ammonium 
hydroxide were obtained from Kemika 
(Zagreb, Croatia). FF and CAP standard 
stock solutions were prepared in 
methanol at the concentration of 1.0 mg/
mL and stored at 4 °C for one month. 
CAP was used as an internal standard. 
Standard solutions of FF and FFA (0.05, 
0.1, 0.5, 1.0, 2.5, and 5.0 µg/mL), and CAP 
(10.0 µg/mL), were prepared in a solvent 
mixture of water and acetonitrile (80:20 
v/v, pH 3.5) freshly before calibration 
analysis. CSF calibrators were prepared 
by adding the appropriate volumes of FF, 
FFA and CAP standard stock solutions 
into blank CSF to contain the same 
concentrations as standard solutions. 
Before HPLC-analyses, CSF calibrators 
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and CSF samples were purified using a 
solid-phase extraction (SPE) procedure, 
which was selected based on the data 
by Shen et al. (2009) and modified. CSF 
samples (100 µL) were spiked with 10.0 
µg CAP and diluted to 1 mL with solvent. 
AccuBOND ODS C18 cartridges (100 
mg/mL, Agilent Technology, Palo Alto, 
CA, USA) were preconditioned with 
2 mL methanol and 2 mL water. The 
CSF solution (1 mL) was applied to the 
cartridge and washed with 2 mL water. 
Analytes were eluted with 2 mL of a 
mixture of methanol and 5% ammonium 
hydroxide in water (70:30 v/v). The 
extract was evaporated to dryness at 
50 °C under a gentle stream of nitrogen 
gas. The residue was reconstituted in 1 
mL solvent for HPLC analyses.
HPLC instrumentation and method 
validation
The HPLC TSP SpectraSystem 
(Thermo Separation Products, San Jose, 
CA, USA) with diode array detector 
(DAD) was used. Data were analysed 
using the ChromQuest Software Version 
5.0 (Thermo Fisher Scientific, San Jose, 
CA, USA). The separations of FF, FFA 
and CAP were carried out on a Zorbax 
C8 SB column (250 mm x 4.6 mm i.d., 5 
µm; Agilent Technology, Santa Clara, 
CA, USA). The column temperature was 
maintained at 30°C, and the flow rate of 
the mobile phase (Table 1) was kept at 1.0 
mL/min. The injection volume was 30 µL. 
Column eluates were detected at 224 nm 
using a full spectral scanning covering 
the wavelength range spanning from 192 
to 360 nm. Quantification was performed 
using an internal standard method.
The analytical method was validated 
concerning its specificity, linearity, 
accuracy, precision (repeatability 
and intermediate precision), limits of 
detection (LOD), limits of quantification 
(LOQ), and robustness. The specificity 
of the method was assessed by testing 
the level of any interference at FF, FFA 
and CAP retention times in solvent, FF, 
FFA or CAP reference solution, blank 
and spiked CSF samples. Two calibration 
curves per matrix (solvent, CSF) were 
constructed at six (spiked) levels using 
the ratio of FF (FFA) and CAP peak area 
versus FF (FFA) concentration. At each 
level, samples were analysed in triplicate. 
The calculation of the LODs and LOQs 
was based on the standard deviation of 
the response and the slope. Precision 
was assessed in terms of repeatability 
and intermediate precision by analysing 
spiked matrix samples having the FF 
and FFA nominal concentration of 1.0 
µg/mL. Recoveries were determined in 
spiked samples at 50%, 100% and 150% 
of the nominal concentrations. Samples 
were stored at -20 °C and tested during 7 
days to determine the stability of spiked 
and non-spiked standard solutions. The 
matrix effects were evaluated by FF, i.e. 
FFA analysis of non-spiked and spiked 
samples at each concentration level. 
Data were analysed using the one-way 
analysis of variance (ANOVA; P<0.05). 
The uncertainty of the SPE-HPLC-DAD 
method was evaluated according to the 
Eurachem/Citac Guide (Eurachem, 2012). 
The estimation of uncertainty was based 
on method validation studies (overall 
bias, precision, and recovery) and data 
obtained from the calibration certificates 
of standards, balance, volumetric flasks 
and pipettes.
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Results and discussion
The development of the HPLC-DAD 
method for FF and FFA determination in 
CSF was a challenge due to the limited 
number of collected pig CSF samples 
from the control group. Therefore, the 
selection of a reversed-phase C8 column 
was based on published data (Wrzesinski 
and Crouch, 2003; Boison, 2004; Holmes 
et al., 2012). Optimization and robustness 
testing of the HPLC-DAD method 
included combining various mixtures 
of A and B component of mobile phase 
(70:30, 80:20 and 90:10 v/v) at the time of 
gradient elution (Table 1) and isocratic 
elution of the 100% mobile phase (water/
acetonitrile, 80:20 v/v). The mobile phase 
elution conditions present in Table 1 
demonstrated the best FF, FFA and 
CAP optimization results for method 
resolution (RS>2.0), capacity (k’>1), 
asymmetry (1.0) and efficiency (N>2000).
The SPE technique was selected 
to achieve easier and faster FF and 
FFA extraction from CSF samples. 
Furthermore, the criterion was also 
to select a solvent that would provide 
efficient extraction and high recoveries 
for FF, FFA and CAP. FFA is a polar 
amphenicol, a weak base that mainly 
exists in cationic form in acid solution, 
meaning that FFA has a better solubility 
at high pH (Zhang et al., 2008). Only the 
non-polar amphenicols FF and CAP are 
efficiently extracted from C18 cartridges 
when using acetonitrile, ethyl acetate or 
methanol as eluents. To increase recovery 
of the FFA, a mixture of methanol and 
a 5% aqueous ammonium hydroxide 
solution was used. This extraction yielded 
good recoveries for FF and FFA (Table 2). 
The validation results for the FF 
and FFA determination in CSF samples 
with the SPE-HPLC-DAD method are 
summarised in Table 2. Calibration curves 
were obtained using linear regression 
analysis and the ratio of the standard 
area to internal standard area over the 
analyte concentration. The coefficients 
of determination (R2) were higher than 
0.99, indicating acceptable linearity in 
the tested range from 0.05 to 5.0 µg/mL 
for standard and spiked samples. The 
sensitivity of the method was established 
from the LOD and LOQ. In the calculation 
of LODs and LOQs, the residual standard 
deviation of a regression line was used as 
the standard deviation. The SPE-HPLC-
DAD method used for the FF and FFA 
determination in CSF ensured LOD at 
0.0023 µg/mL for FF and 0.0100 µg/mL 
for FFA. Recently reported LOQs for FF 
in pig plasma are in the range from 0.04 
to 0.10 µg/mL (Geng et al., 2015; Qian 
et al., 2017; de Smet et al., 2018). Our 
method achieved a lower LOQ for FF in 
CSF (0.007 µg/mL). However, it should be 
taken into account that the CSF in relation 
to plasma is a clear, colourless, nearly 
acellular, low protein fluid, meaning that 
CSF purification is easier. The specificity 
of the SPE-HPLC-DAD method was 
checked by the preparation and analysis 
of blank and spiked pig CSF samples 
obtained from the control group. Typical 
chromatograms of standard solution, 
blank pig CSF and fortified CSF sample 
are shown in Figure 2. The retention times 
of either analytes or internal standard 
in spiked CSF samples are identical to 
the peaks in the standard solution. No 
interfering peaks were observed in the 
blank CSF at the retention time of FF, FFA 
or CAP. Repeatability and intermediate 
precision were below 1.0%. Accuracy was 
studied using fortified blank CSF samples 
having FF and FFA concentrations of 
0.5, 1.0 and 1.5 µg/mL. Six replicates 
per concentration were analysed. Mean 
recovery was 99.8% ± 1.0% RSD for FF, 
and 94.1% ± 9.5% RSD for FFA. All these 
results showed acceptable precisions and 
satisfactory recoveries.
The matrix effect was characterized 
by the matrix factor, i.e. the ratio between 
the FF (FFA) peak response extracted 
from the spiked CSF sample over the 
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FF (FFA) peak response extracted from 
the standard solution. Quantitative 
measurement of the matrix effect was 
evaluated in the range from 0.05 to 5.0 
µg/mL. The matrix effect was eliminated 
by comparing the results of spiked CSF 
sample after extraction (R2: 0.999 for 
FF, 0.996 for FFA) with the standard 
solution (R2: 0.998 for FF, 0.993 for FFA) 
at the same concentrations. Carryover 
effect was also observed by injecting 
blank pig CSF solution after injection of 
the 0.05 µg/mL standard. No carryover 
was quantified. Stability of FF, FFA and 
CAP in CSF was assessed in triplicate 
on spiked samples at concentrations of 
0.5, 1.0 and 1.5 µg/mL after five freeze-
thaw cycles during 7 days. The results 
were compared with those obtained from 
freshly prepared samples. The deviation 
from the initial concentrations of the FF, 
FFA and CAP was below 1.7% for all 
stability experiments.
To ensure correct interpretation 
and comparison of the results, the 
measurement uncertainty of the SPE-
HPLC-DAD methods for FF and FFA in 
pig CSF was evaluated. Nine individual 
sources of uncertainty were taken into 
account (Table 3). They were associated 
with standard purity, uncertainty of the 
balance, volume of flasks and pipettes, 
and the calibration curve, repeatability, 
and accuracy of the method. A coverage 
factor of 2 was decided to be used at 
the confidence level of 95% to estimate 
the expanded uncertainty for FF and 
FFA (Eurachem, 2012). Significant 
contributions to the combined standard 
uncertainty were associated with 
recoveries for FF and FFA. This was 





Linearity range (µg/mL) 0.05 - 5.0
slope 2.109 0.992
intercept - 0.020 - 0.007
R 2 0.993 0.992
Precision intraday (% RSD) 0.26 0.37
intermediate (n = 12; % RSD) 0.38 0.67
Accuracy 50% recovery (mean% ± SD) 111.76 ± 1.20 98.75 ± 7.68
100% recovery (mean% ± SD) 100.95 ± 1.15 91.92 ± 3.62
150% recovery (mean% ± SD) 86.58 ± 0.64 91.74 ± 17.12
Sensitivity LOD (µg/mL) 0.0023 0.0100
LOQ (µg/mL) 0.0071 0.0303
RSD - relative standard deviation; SD - standard deviation
Figure 2. Typical SPE-HPLC-DAD chromatograms 
of blank CSF (■), spiked CSF solution (■) and 
standard solution (■)
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expected, given the challenges involved 
in the selection of SPE eluent for polar 
and non-polar amphenicols.
In our preliminary study of FF 
availability in pig plasma after repeated 
intramuscular administration of 
reference and generic VMP (Šandor et 
al., 2012), FF was detected at 216 hours. 
The mean plasma concentrations of FF 
were quantified in three pigs treated 
with reference VMP (0.033 ± 0.003 µg/
mL) and in four pigs treated with 
generic VMP (0.082 ± 0.007 µg/mL). In 
addition to our preliminary FF results 
in pig plasma and considering the CSF 
composition and formation, the purpose 
of the present study was to explore FF 
disposition in pig CSF at 216 hours after 
the first application of both VMPs. The 
disposition of FFA was also investigated 
















Standard purity ± 0.5% rectangular ∞ 0.0029 - 0.0029
Balance ± 1.8E-07 g* normal ∞ 8.7E-06 - 0.0009
Volume, 10 mL ± 0.04 mL rectangular ∞ 0.023 - 0.0023
Pipette 0.1 mL ± 0.02% rectangular ∞ 0.00012 - 0.0012
Pipette 0.5 mL ± 0.1% rectangular ∞ 0.0006 - 0.0012
Pipette 1 mL ± 0.2% rectangular ∞ 0.0012 - 0.0012
A
Calibration curve
FF 1.0915 µg/mL normal 17 - 0.02 0.004
FFA 1.0499 µg/mL normal 17 - 0.01 0.002
Repeatability
FF 0.7684 µg/mL normal 5 - 0.008 0.004




8 - 1.0 0.003
FFA 94.1% 8 - 8.9 0.03
SPE-HPLC-DAD for FF
Combine standard uncertainty type B 0.007
Combine standard uncertainty type A 0.004
Expanded uncertainty 0.02 µg/mL
SPE-HPLC-DAD for FFA
Combine standard uncertainty type B 0.030
Combine standard uncertainty type A 0.004
Expanded uncertainty 0.07 µg/mL
* U balance = 1.8E-05+ 1.4E-6 x W (g); where W is the nominal value of weight (0.010 g).
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to determine the elimination route of FF 
metabolites (FFA, FF alcohol, FF oxamide 
monochloride FF) via blood. Figure 3 
shows the CSF chromatograms of the 
treated pigs. The SPE-HPLC-DAD results 
showed no FF or FFA disposition in CSF 
samples collected from pigs treated with 
a reference or generic VMP in the period 
from 216 to 384 hours after the first drug 
administration. 
The blood-brain barrier formed by 
brain capillary endothelial cells in the 
central nervous system (CNS) could pre-
vent the passage of FF and FFA into the 
pig CNS from the circulating blood after 
application of the recommended dose. 
However, de Craene et al. (1997) reported 
the maximum FF concentration in calves 
CSF at 2 hours after intravenous treat-
ment. This is different than in our study, 
though those data are not fully compa-
rable due to the different target species, 
time of CSF sampling, dose and route of 
administration. Nevertheless, addition-
al studies are necessary for a better un-
derstanding of FF and FFA distribution. 
New studies should be conducted on CSF 
samples obtained from pigs a short time 
after the first drug administration. The 
data obtained in the present study could 
be valuable for further studies of FF and 
FFA in pig CSF after intramuscular ad-
ministration of VMP.
Conclusions
Optimization and validation 
demonstrated, and the measurement 
uncertainty confirmed, that the SPE-
HPLC-DAD method for FF and FFA 
determination in pig CSF ensures 
good repeatability and reproducibility. 
Considering the nature of biological 
fluids, this method could be suitable for 
further PK studies of FF in pig plasma and 
serum after intramuscular administration 
of VMPs.
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Raspodjela florfenikola (FF) i njegovog 
metabolita florfenikol amina (FFA) u cere-
brospinalnoj tekućini svinja istražena je na-
kon dvokratne primjene u mišić s 48-satnim 
razmakom originalnog i generičkog veteri-
narsko-medicinskog proizvoda (VMP) iste 
terapijske doze (20 mg FF/kg tjelesne mase) u 
istim uvjetima pokusa. Oba VMP-a imaju odo-
brenje za stavljanje u promet u Hrvatskoj te su 
po farmaceutskom obliku otopine za injekcije 
i sadržavaju 300 mg FF/mL. Pokus je proveden 
na klinički zdravim svinjama raspoređenim u 
dvije pokusne i jednu kontrolnu skupinu. Pr-
voj pokusnoj skupini životinja primijenjen je 
originalni, drugoj skupini generički lijek, dok 
je treća skupina bila kontrolna. Žrtvovanje ži-
votinja uslijedilo je nakon 216, 288 i 384 sata od 
prvog davanja VMP-a. Uzorci cerebrospinalne 
tekućine prikupljeni su u trenutku žrtvovanja 
i analizirani su optimiranom i validiranom 
tekućinskokromatografskom metodom uz 
detekciju UV-detektorom s nizom fotodioda 
(HPLC-DAD). Obrada uzoraka cerebrospi-
nalne tekućine provedena je ekstrakcijom na 
čvrstoj fazi C18 (SPE). Primjenom SPE-HPLC-
DAD metode ustvrđeno je da matrica ne utje-
če na linearnost FF i FFA u radnom području 
od 0,05 do 5,00 µg/mL te je postignuta granica 
detekcije od 0,0023 µg/mL za FF i od 0,0100 
µg/mL za FFA. Vrijednosti analitičkih povrata 
kreću se od 86,6 % do 111,8 % za FF, odno-
sno od 91,7 % do 98,8 % za FFA. U ovom radu 
je dokazano da je SPE-HPLC-DAD metoda 
selektivna, osjetljiva i pouzdana analitička 
metoda za određivanje FF i FFA u cerebrospi-
nalnoj tekućini. S obzirom na rezultate našeg 
preliminarnog istraživanja FF u plazmi svinja 
tretiranih originalnim, odnosno generičkim 
VMP-om, cilj ovog istraživanja bila je i uspo-
redba distribucije FF u uzorcima plazme i ce-
rebrospinalne tekućine svinja nakon 216. sata 
od primjene VMP-a. Međutim, u uzorcima 
cerebrospinalne tekućine svinja žrtvovanih 
u navedenom pokusnom razdoblju nisu de-
tektirani ni FF ni FFA. Zbog sličnosti matrica, 
SPE-HPLC-DAD metoda mogla bi poslužiti u 
budućim farmakokinetičkim studijama FF u 
uzorcima plazme i seruma dobivenim od svi-
nja nakon primjene u mišić.
Ključne riječi: florfenikol, florfenikol amin, 
svinje, cerebrospinalna tekućina, veterinarsko-
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